BBSRC Portfolio Analyser
Award details
Structure-based inhibitor design and vaccine development using carbohydrate-binding bacterial toxins
Reference
SBD07527
Principal Investigator / Supervisor
Professor Steve Homans
Co-Investigators /
Co-Supervisors
Dr Rob Field
,
Professor James Naismith
,
Professor Richard Randall
Institution
University of Leeds
Department
Inst of Molecular & Cellular Biology
Funding type
Research
Value (£)
236,406
Status
Completed
Type
Research Grant
Start date
01/10/1997
End date
01/04/2001
Duration
42 months
Abstract
Enteropathogenic Escherichia coli, in common with a variety of other pathogenic bacteria produce cytotoxins associated with diarrhoeal diseases. In addition to presenting serious problems in the Third World, these toxins are responsible for conditions such as haemolytic uraemic syndrome (HUS) in infants, which is the largest cause of kidney failure in this age group. We plan to use structural information on the carbohydrate-binding B subunits of these toxins in a multidisciplinary programme aimed at inhibitor design and to exploit the carbohydrate-binding activity of these toxins as a general tool in the design of potential mucosal vaccines.
Summary
unavailable
Committee
Closed Committee - Biomolecular Sciences (BMS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
Structural biology and design applications (SBD) [1996]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search